Trial
NCT00814372
Evaluate Safety and Effectiveness of MBX-102 in Type 2 Diabetes Patients With Poor Glycemic Control on Metformin
Phase IITERMINATEDEFFICACY/FUTILITYConfidence: MEDIUM
Sponsor
Gilead Sciences
Collaborators
—
Condition
Type 2 Diabetes Mellitus
Intervention
MBX-102
Why stopped
MBX-102 did not meet the target efficacy profile of HbA1c change.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2015-04-17